Dana Pizzuti

Insider Reports History

Location
San Diego, CA
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dana Pizzuti:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Chief Med and Dev Officer Common Stock 66,837 $3,009,001 $45.02 01 Dec 2025 Direct
Crinetics Pharmaceuticals, Inc. Chief Med and Dev Officer Stock Option (Right to Buy) 69,042 01 Dec 2025 Direct

Insider Reports Filed by Dana Pizzuti

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 01 Dec 2025 3 -$140,650 4 Chief Med and Dev Officer 03 Dec 2025, 16:28
CRNX Crinetics Pharmaceuticals, Inc. 03 Nov 2025 4 -$128,862 4 Chief Med and Dev Officer 05 Nov 2025, 17:00
CRNX Crinetics Pharmaceuticals, Inc. 01 Oct 2025 3 -$124,600 4 Chief Med and Dev Officer 03 Oct 2025, 16:41
CRNX Crinetics Pharmaceuticals, Inc. 02 Sep 2025 3 -$76,050 4 Chief Med and Dev Officer 04 Sep 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 22 Aug 2025 3 -$406,200 4 Chief Med and Dev Officer 26 Aug 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 20 Aug 2025 1 -$189,437 4 Chief Med and Dev Officer 21 Aug 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 19 Mar 2025 2 -$86,021 4 Chief Med and Dev Officer 21 Mar 2025, 18:34
CRNX Crinetics Pharmaceuticals, Inc. 20 Feb 2025 2 $0 4 Chief Med and Dev Officer 24 Feb 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 03 Feb 2025 3 -$110,900 4 Chief Med and Dev Officer 05 Feb 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 03 Jan 2025 5 -$478,900 4 Chief Med and Dev Officer 07 Jan 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 03 Oct 2024 3 -$542,512 4 Chief Med and Dev Officer 07 Oct 2024, 07:55
CRNX Crinetics Pharmaceuticals, Inc. 03 Jul 2024 3 -$402,212 4 Chief Med and Dev Officer 05 Jul 2024, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 24 Jun 2024 3 -$273,980 4 Chief Med and Dev Officer 25 Jun 2024, 17:03
CRNX Crinetics Pharmaceuticals, Inc. 15 Apr 2024 3 -$396,462 4 Chief Med and Dev Officer 17 Apr 2024, 16:36
CRNX Crinetics Pharmaceuticals, Inc. 20 Mar 2024 7 -$421,970 4 Chief Med and Dev Officer 22 Mar 2024, 16:52
CRNX Crinetics Pharmaceuticals, Inc. 18 Mar 2024 1 -$15,676 4 Chief Med and Dev Officer 20 Mar 2024, 18:36
CRNX Crinetics Pharmaceuticals, Inc. 04 Mar 2024 2 $0 4 Chief Med and Dev Officer 06 Mar 2024, 20:00
CRNX Crinetics Pharmaceuticals, Inc. 03 Jan 2024 3 -$260,331 4 Chief Med and Dev Officer 04 Jan 2024, 16:45
CRNX Crinetics Pharmaceuticals, Inc. 21 Dec 2023 3 -$169,427 4 Chief Med and Dev Officer 22 Dec 2023, 18:45
CRNX Crinetics Pharmaceuticals, Inc. 03 Apr 2023 2 -$201,146 4 Chief Development Officer 05 Apr 2023, 19:12
CRNX Crinetics Pharmaceuticals, Inc. 01 Mar 2023 2 $0 4 Chief Development Officer 03 Mar 2023, 15:44
CRNX Crinetics Pharmaceuticals, Inc. 10 Oct 2022 2 $0 4 Chief Development Officer 11 Oct 2022, 16:35
CRNX Crinetics Pharmaceuticals, Inc. 30 Sep 2022 0 $0 3 Chief Development Officer 11 Oct 2022, 16:30